SERA / Sera Prognostics, Inc. (SERA) Reports Q1 Loss

Sera Prognostics, Inc. (SERA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combin more_horizontal

The heavy selling pressure might have exhausted for Sera Prognostics, Inc. (SERA) as it is technically in oversold territory now. In addition to this more_horizontal

Sera Prognostics, Inc. (NASDAQ:SERA ) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Peter DeNardo – Investor Relat more_horizontal

Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarke more_horizontal

Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares more_horizontal

Sera Prognostics, Inc. (NASDAQ:SERA ) Q4 2022 Earnings Conference Call March 22, 2023 5:00 PM ET Company Participants Peter DeNardo - CapComm Partners more_horizontal

Sera Prognostics, Inc. (SERA) delivered earnings and revenue surprises of 26.19% and 50%, respectively, for the quarter ended December 2022. Do the nu more_horizontal

The stock price of Sera Prognostics Inc (NASDAQ: SERA) surged by 127.69% this past week. This is why. more_horizontal